邹平哪里有算命先生(平阴哪里有易经算命) (今日更新中)

A "miracle drug" aimed at helping offenders in Arizona jails and prisons beat an Opioid addiction is having limited success, roughly nine months after two separate programs launched.Both the Arizona Department of Corrections and Maricopa County Correctional?Health Services launched separate but similar Vivitrol programs in the summer of 2017.Vivitrol is an injectable form of Naltrexone and designed to block the brain's opioid receptors. Essentially, the monthly shot is designed to prevent an opioid user from getting high.However, experts warn counseling must come along with the medication. Eligible inmates receive a shot of Vivitrol before their release, with counseling and services set up to try and ensure success once back in the community. According to the Arizona Department of Corrections, 13 eligible inmates enrolled in the program since August, with just two making it to their third shot after leaving prison.In Maricopa County, nine eligible county inmates have opted for Vivitrol. Of those nine, county officials only know of three who continued seeking treatment after leaving jail. "I can say that I would have hoped for a better success rate," said Dr. Grant Phillips, the Medical Director for Maricopa County Correctional Health Services.  He also noted the number of people who become eligible for the treatment program is intentionally kept low, to ensure they are providing proper education and services, such as counseling, for when the inmate leaves jail. Essentially, it's a small sample size, but Vivitrol will continue as an option as a part of their larger substance abuse program. "The drug itself is effective when used in combination with counseling and strong social support," Phillips said. "Let's face it, someone leaving jail is lacking in a lot of those things."Phillips says while only nine patients have opted for Vivitrol, they have more than 100 methadone patients just in 2018. "There may be a lack of interest," Phillips said, noting inmates in the substance abuse program regularly discuss various treatment methods.  "Some will have had good experiences, some will not have good experiences, they'll talk about it and they'll kind of share these ideas."The goal is to help inmates better their lives while reducing the rate at which offenders wind up back behind bars. Vivitrol programs take many different shapes across the country. For example, in Madison County, Indiana, Vivitrol is sometimes tied to a condition of probation.The Chief Probation Officer there said roughly 55 percent of participants either successfully completed, or are still a part of, their Vivitrol program. They count that as a success. Perhaps it's too early to evaluate the programs here in Arizona. "The anecdotal success is a reason to be optimistic about it," Phillips said. "Offering choice of all the options that are out there and realizing that Vivitrol is going to work for some individuals, we want to make sure it is available to them." 3177

“To our family of Fast fans everywhere, we feel all the love and the anticipation you have for the next chapter in our saga. That’s why it’s especially tough to let you know that we have to move the release date of the film. It’s become clear that it won’t be possible for all of our fans around the world to see the film this May. We are moving the global release date to April 2021, with North America opening on April 2. While we know there is disappointment in having to wait a little while longer, this move is made with the safety of everyone as our foremost consideration. Moving will allow our global family to experience our new chapter together. We’ll see you next spring.”The postponements of these films comes after the release date for the next Bond film, "No Time to Die," was pushed back to November: 824

A 102-year-old woman in New Hampshire survived COVID-19 earlier this summer. Which is a remarkable feat as America marks about 200,000 deaths from the coronavirus. What makes Mildred Geraldine “Gerri” Schappals' survival more incredible is that she survived the Spanish Flu when she was an infant, then 2 bouts with cancer later in life. 345

“Today I'm donating convalescent plasma,” Judy Lutkin said.“This will be my third time donating.” Lutkin had COVID-19 back in April. “I was pretty sick for about four or five days,” she said. Now she comes infrequently to donate plasma. “It doesn't hurt. It doesn't feel bad. It’s fairly easy.”Plasma is just one of the tools used in fighting coronavirus. As it gets donated, it goes to COVID patients.Since early April, when Vitalant started collecting these donations, they’ve collected more than 9,700 donations equaling more than 33,000 units.“You could help as many as five patients with one sitting,” Liz Lambert, Vitalant spokesperson, said.Vitalant is a nonprofit that collects blood for about 1,000 hospitals across the country.“Right now, there's an emergency need for convalescent plasma as we anticipate more patients will be getting that treatment, or hospitals will be wanting to use that treatment,” Lambert said.The FDA issued an emergency use authorization for convalescent plasma as a potential COVID-19 treatment in late August. Convalescent plasma is taken from the blood of someone who’s already contracted a particular illness, in this case, COVID-19.This isn’t the first time in history; it’s been used to treat a virus.“Convalescent plasma is a very historic and crude way of conferring so-called passive immunity to patients who have a viral or bacterial disease,” Doctor Phil Stahel, Chief Medical Officer at the Medical Center of Aurora, said.So far, this center has treated 100 COVID-19 patients using this method.“Studies have shown that convalescent plasma is very safe,” he said. “It has been recently used for Ebola and other viral diseases for which we do not have a vaccination.”Doctor Stahel said patients they treat who are significantly sick could recover within 24 to 48 hours.Here’s how it works.“Antibodies are proteins that we form in our blood that attack antigens once our immune system recognizes them. It takes weeks for these to develop,” Doctor Ralph Vassallo, Chief Medical & Scientific Officer for Vitalant, said.The antibodies are taken from a recovered patient and put in a patient who recently contracted the disease.“The idea of convalescent plasma is to give them, in that period, when the patient does not have their immune response, to help neutralize the virus and prevent it from infecting cells in the body,” Doctor Vassallo said. “Convalescent plasma has been used for over 100 years in respiratory infections, including influenza.”With more hospitals using convalescent plasma to help COVID-19 patients, blood donation centers hope to identify more plasma donors who have recovered from the virus.“Whether its blood or convalescent plasma, there is a constant need,” Lambert said.Vitalant checks every regular blood donor for the antibodies as well, in hopes of identifying more possible donors.“In the first couple of September, it’s been about 3.6% nationwide,” Dr. Vassallo said.Those interested in donating convalescent plasma need to meet the same requirements as a blood donor, like being 16 years old or older, and at least 110 pounds.However, they also need to have a doctor-referred case of COVID-19 or doctor-referred antibody test.“It is indeed the first line of defense, and we should treat those patients early. This is for the adult in patients who are severely sick and at risk of getting on a ventilator, which we try to avoid by all means,” Doctor Stahel said. 3450

(KGTV) — Suspicious packages addressed to Sen. Kamala Harris (D-CA) and billionaire Tom Steyer were intercepted Friday morning in California, according to authorities.The package addressed to Steyer, who has pushed efforts to impeach President Trump, was intercepted in Burlingame, Calif., according to CNN.The Sacramento Bee reported that a local post office worker alerted authorities around 8 a.m. to a package intended for Sen. Harris. While Sheriffs' investigators could not confirm it was addressed to Sen. Harris, another source did.RELATED:  577

来源：资阳报